Bruce L. Jacobs1, Marc C. Smaldone1, Vikas Tyagi1, Brian J. Philips1, Stephen V. Jackman1, Wendy W. Leng1, Pradeep Tyagi2
Canadian Journal of Urology, Vol.17, No.1, pp. 4989-4994, 2010
Abstract Objectives: Studies have suggested that pathology of the lower urinary tract can be detected by following changes in urinary proteins. We evaluated urine nerve growth factor (NGF) levels from patients with a variety of urologic conditions to examine NGF's role as a future biomarker.
Materials and methods: Urine samples were obtained from 72 patients with normal non-diseased urinary tracts (n=13), neurogenic overactive bladder (NOAB) (n=13), idiopathic overactive bladder (OAB) (n=17), interstitial cystitis/painful bladder syndrome (IC/PBS) (n=8), prostate cancer (n=7), history of prostate cancer status post robot-assisted laparoscopic prostatectomy (RALP) (n=6), active bladder cancer (n=4), and nephrolithiasis (n=4).… More >